Hironori Ueno
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Chronic-phase chronic myeloid leukemia complicated by dasatinib-associated lymphadenopathy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Bortezomib With High-dose Melphalan Conditioning Regimen in Newly Diagnosed Multiple Myeloma Patients: Long-term Follow-up.
Journal: In vivo (Athens, Greece)
Published: August 31, 2024
Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 07, 2021
Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma.
Journal: In vivo (Athens, Greece)
Published: May 01, 2020
Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study.
Journal: Leukemia & lymphoma
Published: March 12, 2020
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever.
Journal: Mycoses
Published: November 19, 2019
Occurrence of acquired factor V inhibitor during antibiotic therapy for a surgical wound infection
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 07, 2018
Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission.
Journal: Internal medicine (Tokyo, Japan)
Published: July 10, 2018
Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.
Journal: American journal of hematology
Published: April 26, 2017
Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-host Disease.
Journal: Hematology reports
Published: March 05, 2017
Last Updated: 09/26/2026